FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Lesinurad (ZURAMPIC) Tablets
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Ironwood Pharmaceuticals Inc. (New 04/15/2019)

Company Contact Information:
844-374-4793

Presentation Posting Date Related Information
ZURAMPIC® (lesinurad) 200 mg tablets 5 count bottle (NDC 70785-011-05) 04/15/2019 Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Zurampic.
ZURAMPIC® (lesinurad) 200 mg tablets 30 count bottle (NDC 70785-011-30) 04/15/2019 Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Zurampic.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English